a public good project by the
Synthesis
Company
of California

© 2026

Jürgen Serth | doi.page

0 works0 citations0 h-index

Jürgen Serth

Medizinische Hochschule Hannover(DE)

Publications by Year

Research Areas

Renal cell carcinoma treatment, Epigenetics and DNA Methylation, Renal and related cancers, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments

Most-Cited Works

→ Identification of seven new prostate cancer susceptibility loci through a genome-wide association study(2009)423 cited
→ p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder(1995)142 cited
→ Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer(2010)121 cited
→ DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detection(2009)107 cited
→ Quantitation of DNA Extracted after Micropreparation of Cells from Frozen and Formalin-Fixed Tissue Sections(2000)99 cited
→ The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures.(1991)87 cited

→ Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma(2013)

75 cited

Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.(1999)

→ Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues(2003)67 cited

→ RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis(2007)64 cited